NM_014946.4:c.280G>A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_014946.4(SPAST):​c.280G>A​(p.Gly94Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000276 in 1,449,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

SPAST
NM_014946.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.473

Publications

0 publications found
Variant links:
Genes affected
SPAST (HGNC:11233): (spastin) This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018]
SPAST Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, Ambry Genetics
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • SPAST-related motor disorder
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 148 curated pathogenic missense variants (we use a threshold of 10). The gene has 21 curated benign missense variants. Gene score misZ: 1.2438 (below the threshold of 3.09). Trascript score misZ: 0.22274 (below the threshold of 3.09). GenCC associations: The gene is linked to hereditary spastic paraplegia 4, SPAST-related motor disorder, Charlevoix-Saguenay spastic ataxia, neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.19762555).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPASTNM_014946.4 linkc.280G>A p.Gly94Arg missense_variant Exon 1 of 17 ENST00000315285.9 NP_055761.2 Q9UBP0-1E5KRP5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPASTENST00000315285.9 linkc.280G>A p.Gly94Arg missense_variant Exon 1 of 17 1 NM_014946.4 ENSP00000320885.3 Q9UBP0-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000920
AC:
2
AN:
217472
AF XY:
0.00000842
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000212
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000276
AC:
4
AN:
1449000
Hom.:
0
Cov.:
35
AF XY:
0.00000278
AC XY:
2
AN XY:
719698
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33224
American (AMR)
AF:
0.00
AC:
0
AN:
42808
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25810
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39260
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84576
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51972
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5226
European-Non Finnish (NFE)
AF:
0.00000362
AC:
4
AN:
1106370
Other (OTH)
AF:
0.00
AC:
0
AN:
59754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000167
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 4 Uncertain:1
Nov 15, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 94 of the SPAST protein (p.Gly94Arg). This variant is present in population databases (rs750218565, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with SPAST-related conditions. ClinVar contains an entry for this variant (Variation ID: 572264). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SPAST protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.042
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
14
DANN
Benign
0.90
DEOGEN2
Benign
0.14
T;T;.;.;.;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.71
.;T;T;.;T;T;T;T
M_CAP
Pathogenic
0.92
D
MetaRNN
Benign
0.20
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
0.0
N;N;N;N;.;.;.;.
PhyloP100
-0.47
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
0.54
N;.;N;.;.;.;.;.
REVEL
Uncertain
0.33
Sift
Benign
0.60
T;.;T;.;.;.;.;.
Sift4G
Benign
0.23
T;T;T;.;.;.;.;.
Polyphen
0.0
B;B;.;.;.;.;.;.
Vest4
0.13
MutPred
0.22
Gain of MoRF binding (P = 0.013);Gain of MoRF binding (P = 0.013);Gain of MoRF binding (P = 0.013);Gain of MoRF binding (P = 0.013);Gain of MoRF binding (P = 0.013);Gain of MoRF binding (P = 0.013);.;.;
MVP
0.27
MPC
0.15
ClinPred
0.057
T
GERP RS
-0.88
PromoterAI
0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.046
gMVP
0.14
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750218565; hg19: chr2-32289180; API